Mayo Clinic Trial on CBT for Quality of Life in Stage III-IV Melanoma Patients
A clinical trial is assessing the impact of cognitive behavioral therapy on quality of life for stage III-IV melanoma patients post-treatment.
Indication
Clinical and regulatory intelligence for Melanoma with 14 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.